The largest database of trusted experimental protocols

F ab 2 goat anti human igm

Manufactured by Jackson ImmunoResearch
Sourced in United States

F(ab)2 goat anti-human IgM is a laboratory reagent used for the detection and quantification of human IgM antibodies. It is produced by pepsin digestion of goat-derived anti-human IgM antibodies, resulting in the F(ab)2 fragment. This fragment retains the antigen-binding capability of the original antibody but lacks the Fc region.

Automatically generated - may contain errors

14 protocols using f ab 2 goat anti human igm

1

Inducing B-cell Receptor Crosslinking

Check if the same lab product or an alternative is used in the 5 most similar protocols
To induce B-cell receptor crosslinking, OSU-CLL and MEC-1 were treated with 10 µg/mL of goat F(ab’)2 anti-human IgM (Jackson ImmunoResearch, West Grove, PA, USA) for the final 15 min of treatment. Cells were then harvested and lysed for immunoblot analyses.
+ Open protocol
+ Expand
2

Multiparameter Immune Cell Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
ERK1/2, phospho-ERK1/2 (Thr202/Tyr204), Akt (pan), phospho-Akt (S473), CD79b, CD79a, phospho-CD79a (Tyr182), SHP1, phospho-SHP1 (Tyr564), SHIP1, phospho-SHIP1 (Tyr1020), BTK, phospho-BTK(Tyr223), NF-kB p65, phospho–NF-kB p65 (ser536), IgM, Lyn, phospho-Lyn (Y507), LCK, CD86, and ZAP70 antibodies were from Cell Signaling Technology (Beverly, MA). Anti-SRC family (phospho-Y418)–phospho-Lyn (Y396), CD62L, and IgG antibodies were from Abcam (Cambridge, UK). Purified anti-human actin antibody was obtained from MP Biomedicals (Illkirch, France). Goat anti Rabbit IgG (H+L)–HRP conjugate and Goat anti Mouse IgG (H+L)–HRP conjugate, Goat F(ab′)2 anti-human IgM and Goat F(ab′)2 anti-human IgG were from Jackson Immunoresearch Laboratories (West Grove, PA). All antibodies utilized in the study were used in concentrations according to the manufacturer’s instructions. Ficoll-Paque PLUS from GE healthcare (Uppsala, Sweden), dimethyl sulfoxide (DMSO) from Merck (Darmstadt, Germany), RPMI, fetal calf serum (FCS), Dulbecco’s phosphate-buffered saline (PBS), L-glutamine, and penicillin-streptomycin from Biological Industries (Beit-Haemek, Israel) were utilized for cell cultures.
+ Open protocol
+ Expand
3

Regulation of IL-10 and Apoptosis in CD5+ B Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Splenocytes were stimulated with 10 µg/mL of affinity purified polyclonal goat F(ab’)2 anti-human IgM (Jackson ImmunoResearch) for 24 h at 37°C in the presence or absence of humanized anti-human FasL-neutralizing mAb (RNOK203) or the general caspase inhibitor Z-VAD-FMK (BD Biosciences). During the last 6 h of incubation, cultures were stimulated with PMA and ionomycin in the presence of Golgi-Plug, followed by surface staining and intracellular detection of IL-10 and active caspase 3 using specific mAbs. It is noteworthy that number of cells obtained per sample was limiting and did not allow a more direct and extensive analysis such as multi-color FACS analysis for FasL, Fas, CD5 on B cells without culture with anti-FasL mAb. Such analysis would have directly addressed whether IL-10-producing CD5+ B cells are specifically targeted for apoptosis.
+ Open protocol
+ Expand
4

Stimulating Tumor Microenvironment Signals

Check if the same lab product or an alternative is used in the 5 most similar protocols
SpiD3, SpiD7, and analog 19 were synthesized at University of Nebraska Medical Center (UNMC; Omaha, NE) following reported procedures (13–15 (link)). Thapsigargin, cycloheximide, z-VAD(OMe)-FMK, ibrutinib, and JQ-1 were purchased from Cayman Chemical. TPCA-1 was purchased from Sigma-Aldrich. All pharmacologic agents/inhibitors were dissolved in DMSO. Stimulants used to mimic TME signals included 20 ng/mL TNFα (Cayman Chemical), 500 ng/mL recombinant human (rh) sCD40 ligand (Peprotech), 50 ng/mL rhBAFF ligand (Peprotech), 10 µg/mL goat F(ab)2 anti-human IgM (Jackson ImmunoResearch), 3.2 µmol/L CpG oligonucleotides 2006 (CpG; Integrated DNA Technologies), 1X lipopolysaccharide (Invitrogen), and 1X phorbol 12-myristate 13-acetate/Ionomycin (BioLegend).
+ Open protocol
+ Expand
5

Phosphorylation of B Cell Signaling Intermediates

Check if the same lab product or an alternative is used in the 5 most similar protocols
Five unrelated healthy adult volunteers were studied, each on a different day. Peripheral blood B cells were isolated as described in the Cell purification and cell culture conditions for in vitro treatment section. For phosphorylation assays, glucocorticoid- or vehicle-treated B cells were stained with mAbs against CD19, CD27, CD10, and IgD, as detailed in the Assessment of B cell surface markers section, then stimulated with 10 µg/ml goat F(ab′)2 anti-human IgM (Jackson ImmunoResearch Laboratories) at 37°C for 2 min. For the detection of phosphorylated signaling intermediates, cells were fixed and permeabilized using BD Cytofix and Phosflow Perm/Wash buffers (BD Biosciences) and stained separately with a PE-conjugated mAb against phosphorylated PLC-γ2 (pY759) clone K86-689.37 (BD Biosciences), or an unconjugated polyclonal antibody against phosphorylated CD79A(Tyr182) (Cell Signaling Technology; cat. no. 5173) followed by staining with secondary goat anti-rabbit IgG-PE (Thermo Fisher; cat. no. P-2771MP). Flow cytometric analyses were performed as described above.
+ Open protocol
+ Expand
6

BCR and CD40 Crosslinking Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
For BCR crosslinking 1 × 107 cells were treated with goat anti‐human IgM F(ab′)2 (Jackson ImmunoResearch) at 10 μg/mL final concentration for 8‐24 hours. CD40 ligand (R&D Systems) was used at 50 ng/mL final concentration for 1 hour.
+ Open protocol
+ Expand
7

Naïve B Cell Activation and Phenotyping

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sorted naive B cells (1 × 105 in 200 μL per well) were plated and activated with goat anti-human IgM F(ab′)2 (10 μg/mL, Jackson ImmunoResearch), recombinant human CD40L (500 ng/mL, Enzo Life Sciences), IL-21 (100 ng/mL, Gibco, Thermo Fisher Scientific), IFN-γ (50 ng/mL, R&D Systems, Bio-Techne), IL-4 (25 ng/mL, R&D Systems, Bio-Techne), and IL-17 (50 ng/mL, R&D Systems, Bio-Techne). Cells were cultured in complete RPMI and incubated at 37°C for 5 days. Cells were harvested and stained with CD19, CD38, T-bet, CD27, CD11c, IL-21R, and CD71 antibodies before acquisition on a cytometer.
+ Open protocol
+ Expand
8

Cell stimulation and activation assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fresh or thawed cell suspensions were washed in complete medium, counted and 0.7–1.0 × 106 cells per well were seeded in round bottom 96-well culture plates in RPMI-1640 culture medium supplemented with 10% FBS. Cells were stimulated with indicated antibodies or immunostimulants. Stimuli included Leu4 (IgG1) mouse mAb directed against human CD3ε purified from ascites, goat anti-human IgM Fab’2 (Jackson ImmunoResearch Laboratories, Inc.), Staphylococcal enterotoxin E (SEE; ToxinTechnologies), CpG oligonucleotides, ODN 2216 for T cells and CpG ODN 2006 and 1826 for B cells (InvivoGen), Interferon alpha (gift from PBL Interferon Source), LPS from Escherichia coli O111:B4 (Sigma), human recombinant IL-4 (R&D Systems), ionomycin 1  µM (Calbiochem), PMA (phorbol 12-myristate 13-acetate, 20ng ml−1) (Cell signaling).
+ Open protocol
+ Expand
9

BCR-Induced Calcium Mobilization Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
106 DG-75 or Ramos B cells were loaded in 700 µl RPMI containing 5% FCS, 1 µM Indo1-AM (Molecular Probes), and 0.015% Pluronic F127 (Molecular Probes) at 30°C for 25 min. Subsequently, the cell suspension was diluted two-fold with RPMI 10% FCS and incubated for 10 min at 37°C. Cells were washed, treated with 10 µM 1G244 (or mock-treated) and prepared for measurements as described earlier (Stork et al., 2007 (link)). For BCR-induced Ca2+ mobilization, cells were treated with 10 µg/ml F(ab)2 goat-anti-human IgM (Jackson Immunoresearch). Changes in the ratio of fluorescence intensities at 405 nm and 510 nm were monitored on a LSRII flow cytometer (Becton Dickinson) and analysed with FlowJo (TriStar).
+ Open protocol
+ Expand
10

Quantifying Protein Expression in Activated B Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
CpG or LPS pre-treated HBL1 B cells were placed on six-well culture plates previously coated overnight with 100 μg/mL of F(ab′)2 goat anti-human IgM (Jackson Immunoresearch) diluted in cold PBS and then processed to be analyzed by western blot. Band intensity was determined by ImageJ. Normalization of protein expression was performed by calculating the density of the target protein, multiplied by the ratio between the density of the loading control from the control sample (time 0 or untreated) and the density of loading control from the lane of interest. The fold change was calculated by dividing the normalized expression from each lane by the normalized expression of the control sample.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!